FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20191223E00291
1. Date of relevant event: 19/12/2019
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02186
4. Name of listed corporation: 绿叶制药集团有限公司 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 3,268,965,343
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Liu
(Other names) Dianbo
10. Name of director (Chinese): 刘殿波 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
 
 
 		          
 
Short position 
1503You ceased to have a short position in the shares or the number of shares in which you have a short position decreased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2301Trustee
 
2301Trustee
 		 2,038,959           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position1,517,113,93046.41
Short position74,740,9092.29
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position1,517,113,93046.41
Short position72,701,9502.22
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2301Trustee
Long position1,517,113,930
Short position72,701,950
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Short position
4105Unlisted derivatives - Physically settled
 18/12/2020      72,701,950
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Luye Pharmaceutical Investment Co., LtdPO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsLuye Pharmaceutical International Co., Ltd.100.00Y
Long position1,517,113,930
Short position72,701,950
Luye Pharmaceutical International Co., LtdPO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsLuye Pharma Holdings Ltd.100.00N
Long position1,517,113,930
Short position72,701,950
Luye Pharma Holdings Ltd.Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman IslandsLuye Life Sciences Group Ltd100.00N
Long position1,517,113,930
Short position72,701,950
Luye Life Sciences Group LtdClarendon House, 2 Church Street, Hamilton HM 11, BermudaNelumbo Investments Limited70.00N
Long position1,517,113,930
Short position72,701,950
Nelumbo Investments LimitedHelvetia Court, South Esplanade, St Peter Port, GuernseyGinkgo (PTC) Limited100.00N
Long position1,517,113,930
Short position72,701,950
Ginkgo (PTC) LimitedHelvetia Court, South Esplanade, St Peter Port, GuernseyShorea LBG100.00N
Long position1,517,113,930
Short position72,701,950
Shorea LBGHelvetia Court, South Esplanade, St Peter Port, GuernseyLiu Dian Bo100.00N
Long position1,517,113,930
Short position72,701,950
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 本通知所载淡仓申报与Luye Pharmaceutical Investment Co., Ltd（"发行人"）发行可交换债券（“债券”）有关, 可交换债券已经用本金较低的另一笔进行了再融资。 而且，与此相关的股份数量是原始数字74,740,909减去新数字72,701,950，即2,038,959。受限于相关的债券契据所载的条件，债券持有人可行使交换权利，基于每股港币10.77元的初始交换价格，以债券交换发行人持有的若干绿叶制药集团有限公司股份。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 23/12/2019
(dd/mm/yyyy)